Understanding the Clinical Context
Following continuous renal replacement therapy (CRRT) for acute kidney injury (AKI), the patient remains in a critically ill state with significant metabolic and hemodynamic fragility. While CRRT is a life-sustaining intervention that corrects uremia, fluid overload, and electrolyte imbalances, the post-treatment period requires vigilant monitoring for procedure-related complications. The underlying pathophysiology of AKI, often driven by conditions like rhabdomyolysis or sepsis, means the patient’s endothelium and coagulation system are already under stress
[1]. The assessment must therefore differentiate between expected therapeutic effects and emergent, life-threatening adverse events.
Analysis of the Assessment Findings
The nurse must prioritize findings using a systematic approach, evaluating each option for its acuity and potential to cause rapid clinical deterioration.
Option 1: Blood pressure decrease from 160/90 mmHg to 130/80 mmHg.
This finding represents a positive hemodynamic response to CRRT. A primary goal of KRT in AKI is the removal of excess intravascular volume, which directly reduces preload and consequently lowers systemic blood pressure. A post-treatment pressure of
130/80 mmHg is a normotensive value and indicates effective ultrafiltration rather than a complication. This is an expected outcome and does not require immediate intervention beyond routine monitoring.
Option 2: Weight loss of 2.5 kg during the dialysis session.
Weight loss during CRRT is a direct measure of net ultrafiltration and fluid removal. A loss of
2.5 kg in a session is a substantial but clinically targeted goal in a fluid-overloaded patient with AKI. This finding confirms that the prescribed fluid balance was achieved. While the nurse should continue to monitor for signs of intravascular volume depletion, this isolated finding is an anticipated result of the therapy, not an acute crisis.
Option 3: Mild cramping in the lower extremities.
Mild muscle cramping is a relatively common and generally benign complication during or immediately after dialysis. It is often attributed to rapid fluid and electrolyte shifts, particularly a decline in serum sodium or calcium levels, which can transiently alter neuromuscular excitability. While uncomfortable for the patient, this finding is managed with supportive measures and does not signify an immediate threat to life. It is a lower-priority concern compared to findings that suggest cardiopulmonary compromise.
Option 4: Sudden onset of chest pain with shortness of breath.
This is the most concerning finding and demands immediate intervention. The sudden onset of these symptoms in a patient who has just completed CRRT is a classic presentation of a life-threatening thromboembolic event, such as a pulmonary embolism, or an acute coronary syndrome. The pathogenesis is directly linked to the dialysis procedure. Despite the use of anticoagulation strategies like regional citrate anticoagulation (RCA) to maintain circuit patency, critically ill patients with AKI are in a complex state of both hypercoagulability and platelet dysfunction . The extracorporeal circuit itself can activate the coagulation cascade and platelets. Furthermore, the process of CRRT can inadvertently deplete antithrombotic factors. A sudden dislodgement of a microthrombus from the vascular access site or the extracorporeal circuit can rapidly obstruct pulmonary vasculature, causing acute ventilation-perfusion mismatch, hypoxemia, and hemodynamic instability. This represents an immediate threat to airway, breathing, and circulation, requiring rapid assessment, oxygen administration, and emergency notification of the provider.
Clinical Reasoning and Priority Setting
The nurse’s clinical judgment must synthesize the procedure’s therapeutic goals with its inherent risks. Options 1 and 2 are indicators of effective therapy, and Option 3 is a non-life-threatening side effect. In contrast, Option 4 signals a catastrophic complication that can lead to cardiac arrest within minutes. The sudden nature of the chest pain and dyspnea points to an acute vascular occlusion, a recognized critical event in the post-KRT period. This directly aligns with the critical care principle of prioritizing conditions that compromise the ABCs (Airway, Breathing, Circulation) first. The pathophysiological link between the extracorporeal therapy, the patient’s underlying pro-inflammatory state from AKI, and the risk of thrombosis makes this a high-probability, high-impact emergency that overrides all other assessment data
[1].
References (research sources)